Downloaded from http://fn.bmj.com/ on January 3, 2015 - Published by group.bmj.com
Review
Incidence and treatment of infantile haemangioma in preterm infants Rangmar Goelz, Christian F Poets Department of Neonatology, University Children’s Hospital Tuebingen, Tuebingen, Germany Correspondence to Dr Rangmar Goelz, University Children’s Hospital Tuebingen, Department of Neonatology, Calwerstrasse 7, Tuebingen D72076, Germany; Rangmar. [email protected] Received 11 September 2014 Accepted 4 October 2014 Published Online First 28 October 2014
ABSTRACT Infantile haemangioma (IH) are vascular tumours with a unique growth dynamic, mostly absent at birth, growth in the first months followed by involution over several years, often resulting in residual skin changes. Immunehistologically, IH cells are exclusively glucose transporter protein-1 positive.The incidence of IH is increasing with decreasing gestational age, from 1–4% in term infants to 23% in those of
Review
Incidence and treatment of infantile haemangioma in preterm infants Rangmar Goelz, Christian F Poets Department of Neonatology, University Children’s Hospital Tuebingen, Tuebingen, Germany Correspondence to Dr Rangmar Goelz, University Children’s Hospital Tuebingen, Department of Neonatology, Calwerstrasse 7, Tuebingen D72076, Germany; Rangmar. [email protected] Received 11 September 2014 Accepted 4 October 2014 Published Online First 28 October 2014
ABSTRACT Infantile haemangioma (IH) are vascular tumours with a unique growth dynamic, mostly absent at birth, growth in the first months followed by involution over several years, often resulting in residual skin changes. Immunehistologically, IH cells are exclusively glucose transporter protein-1 positive.The incidence of IH is increasing with decreasing gestational age, from 1–4% in term infants to 23% in those of
